1. Home
  2. LSPD vs MPLT Comparison

LSPD vs MPLT Comparison

Compare LSPD & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$9.91

Market Cap

1.4B

Sector

N/A

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$36.56

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSPD
MPLT
Founded
2005
2018
Country
Canada
United States
Employees
N/A
133
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LSPD
MPLT
Price
$9.91
$36.56
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$13.33
$32.67
AVG Volume (30 Days)
797.2K
563.2K
Earning Date
05-21-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.43
N/A
Revenue Next Year
$10.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.83
$12.24
52 Week High
$14.34
$40.43

Technical Indicators

Market Signals
Indicator
LSPD
MPLT
Relative Strength Index (RSI) 48.12 54.74
Support Level $9.87 $26.20
Resistance Level $12.70 $40.43
Average True Range (ATR) 0.34 2.75
MACD -0.10 -0.46
Stochastic Oscillator 32.74 35.78

Price Performance

Historical Comparison
LSPD
MPLT

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc is a one-stop commerce platform providing its customers with the critical functionalities needed to engage with consumers, manage their operations, order their inventory, accept payments, and run their business. It has customers globally in over 100 countries, empowering single- and multi-location small and medium-sized businesses to compete in an omni-channel market environment by engaging with consumers across online, mobile, social, and physical channels. Its products are divided into retail, restaurant, and golf categories. Geographically, it operates in Canada, the United States, the United Kingdom, Switzerland, Germany, and Others with the majority of revenue deriving from Canada.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: